MedPath

A multi-component intervention for smoking cessation among Australian male prison inmates

Phase 3
Completed
Conditions
Mental Health - Addiction
Tobacco Addiction
Registration Number
ACTRN12606000229572
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
426
Inclusion Criteria

Has been incarcerated for >1 month with >6 months of the current sentence remaining; English speaker; scores >5 on the Fagerström Test for Nicotine Dependence (indicates moderate to high nicotine dependence); readiness to quit.

Exclusion Criteria

current significant cardiovascular disease (e.g. evidence of conduction defects on ECG); Current major depressive disorder; bipolar disorder; current antidepressant or antipsychotic medication; threats of suicide or repeated deliberate self harm; current psychotic disorder; use of a monoamine oxidase inhibitors within two weeks; known allergies to the study drugs; life threatening illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Point prevalence abstinence. Point prevalence is defined as the proportion of subjects who have not smoked at all during a particular time period and allows for the inclusion a grace period. [At 12 months. Also reported for the 3 and 6 month follow-ups.];Continued abstinence. Continuous abstinence is defined as abstinence between quit day and a specified follow-up period 3 months, 6 months and 12 months.[At 12 months. Also reported for the 3 and 6 month follow-ups.]
Secondary Outcome Measures
NameTimeMethod
Anxiety & depression measured by the PRIME and Kessler 10 (K-10).[Initial screening.Also reported for 3month, 6 month and 12 month follow ups.];Physical and mental wellness measured by the Short Form 12 (SF-12).[Short Form 12 ( SF-12) Initial screening.Also reported for 3month, 6 month and 12 month follow ups.]
© Copyright 2025. All Rights Reserved by MedPath